BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36354709)

  • 1. Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry.
    Jazmati D; Hero B; Thole-Kliesch TM; Merta J; Deubzer HE; Bäumer C; Heinzelmann F; Schleithoff SS; Koerber F; Eggert A; Schwarz R; Simon T; Timmermann B
    Curr Oncol; 2022 Oct; 29(11):8222-8234. PubMed ID: 36354709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Beam Therapy for Children With Neuroblastoma: Experiences From the Prospective KiProReg Registry.
    Jazmati D; Butzer S; Hero B; Ahmad Khalil D; Merta J; Bäumer C; Plum G; Fuchs J; Koerber F; Steinmeier T; Peters S; Doyen J; Thole T; Schmidt M; Blase C; Tippelt S; Eggert A; Schwarz R; Simon T; Timmermann B
    Front Oncol; 2020; 10():617506. PubMed ID: 33552991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of Proton Beam Therapy for Infants with Brain Tumours: Experiences from the Prospective KiProReg Registry Study.
    Jazmati D; Steinmeier T; Ahamd Khalil D; Frisch S; Peters S; Schulze Schleithoff S; Bäumer C; Rutkowski S; Frühwald MC; Blase C; Tippelt S; Timmermann B
    Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):e295-e304. PubMed ID: 33820696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
    Thorpe CS; Niska JR; Girardo ME; Kosiorek HE; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
    Breast J; 2019 Nov; 25(6):1160-1170. PubMed ID: 31338974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004.
    Jazmati D; Butzer S; Hero B; Doyen J; Ahmad Khalil D; Steinmeier T; Schulze Schleithoff S; Eggert A; Simon T; Timmermann B
    Strahlenther Onkol; 2021 Aug; 197(8):683-689. PubMed ID: 33300099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial.
    Casey DL; Kushner BH; Cheung NV; Modak S; Basu EM; Roberts SS; LaQuaglia MP; Wolden SL
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):409-414. PubMed ID: 30763661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.
    Choi JI; Khan AJ; Powell SN; McCormick B; Lozano AJ; Del Rosario G; Mamary J; Liu H; Fox P; Gillespie E; Braunstein LZ; Mah D; Cahlon O
    Radiother Oncol; 2021 Dec; 165():142-151. PubMed ID: 34688807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma.
    Bagley AF; Grosshans DR; Philip NV; Foster J; McAleer MF; McGovern SL; Lassen-Ramshad Y; Mahajan A; Paulino AC
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27786. PubMed ID: 31050179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for consolidation of metastatic or recurrent sarcomas in children treated with intensive chemotherapy and stem cell rescue. A feasibility study.
    Czyzewski EA; Goldman S; Mundt AJ; Nachman J; Rubin C; Hallahan DE
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):569-77. PubMed ID: 10348286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
    Kushner BH; Cheung NK; Barker CA; Kramer K; Modak S; Yataghene K; Wolden SL
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1181-6. PubMed ID: 19427746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient Transfer to Receive Proton Beam Therapy During Intensive Multimodal Therapy is Safe and Feasible for Patients With Newly Diagnosed High-risk Neuroblastoma.
    Hosaka S; Fukushima H; Nakao T; Suzuki R; Yamaki Y; Tanaka K; Saito T; Mizumoto M; Sakurai H; Fukushima T; Takada H
    J Pediatr Hematol Oncol; 2020 Jan; 42(1):e18-e24. PubMed ID: 31449498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome After Modern Proton Beam Therapy in Childhood Craniopharyngioma: Results of the Prospective Registry Study KiProReg.
    Bischoff M; Khalil DA; Frisch S; Bäcker CM; Peters S; Friedrich C; Tippelt S; Kortmann RD; Bison B; Müller HL; Timmermann B
    Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38492813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial.
    Hotca A; Sindhu KK; Lehrer EJ; Hartsell WF; Vargas C; Tsai HK; Chang JH; Apisarnthanarax S; Nichols RC; Chhabra AM; Hasan S; Press RH; Lazarev S; Hajj C; Kabarriti R; Rule WG; Simone CB; Choi JI
    Adv Radiat Oncol; 2024 May; 9(5):101459. PubMed ID: 38596455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proton Therapy for Primary Bone Malignancy of the Pelvic and Lumbar Region - Data From the Prospective Registries ProReg and KiProReg.
    Worawongsakul R; Steinmeier T; Lin YL; Bauer S; Hardes J; Hecker-Nolting S; Dirksen U; Timmermann B
    Front Oncol; 2022; 12():805051. PubMed ID: 35251976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton Beam Therapy for Pediatric Tumors of the Central Nervous System-Experiences of Clinical Outcome and Feasibility from the KiProReg Study.
    Peters S; Frisch S; Stock A; Merta J; Bäumer C; Blase C; Schuermann E; Tippelt S; Bison B; Frühwald M; Rutkowski S; Fleischhack G; Timmermann B
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry.
    Chhabra AM; Rice SR; Holtzman A; Choi JI; Hasan S; Press RH; Chang J; Halasz L; Tsai HK; Wang CJ; Kabolizadeh P; Gondi V; Hartsell WF; Vora SA; Vargas CE; Simone CB
    Radiother Oncol; 2023 Jun; 183():109551. PubMed ID: 36813169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma.
    Hill-Kayser CE; Tochner Z; Li Y; Kurtz G; Lustig RA; James P; Balamuth N; Womer R; Mattei P; Grupp S; Mosse YP; Maris JM; Bagatell R
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):401-408. PubMed ID: 30738983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.